利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

17 条记录 (耗时 0.023 秒)

    Antiulcer agent and process for preparing the same
    1.
    发明授权
    Antiulcer agent and process for preparing the same 失效
    抗溃疡剂及其制备方法

    公开(公告)号：US5698534A

    公开(公告)日：1997-12-16

    申请号：US202642

    申请日：1994-02-28

    申请人： Masato Nagaoka ,  Shusuke Hashimoto ,  Tsunekazu Watanabe ,  Teruo Yokokura

    发明人： Masato Nagaoka ,  Shusuke Hashimoto ,  Tsunekazu Watanabe ,  Teruo Yokokura

    IPC分类号： A61K31/70 ,  A61K31/715 ,  A61P1/04 ,  C07H3/08 ,  C08B37/00 ,  C12P19/06 ,  C12R1/01

    CPC分类号： A61K31/7004 ,  A61K31/715

    摘要： An antiulcer agent effective on prevention of ulceration and acceleration of healing of ulcers and processes for preparing the same are disclosed. The antiulcer agent comprises rhamnan (a homopolysaccharide), rhamnose or a rhamnose oligomer as an active ingredient. Rhamnan is prepared by separating rhamnan sulfate from rhamnan sulfate-containing algae and desulfurating the rhamnan sulfate. Rhamnan oligomers are prepared by hydrolyzing rhamnan obtained by desulfuration of rhamnan sulfate or by hydrolyzing microbial cells of a Bifidobacterium or polysaccharides separated therefrom.

    摘要翻译： 公开了一种有效预防溃疡溃疡和加速溃疡愈合的抗溃疡剂及其制备方法。 抗溃疡剂含有作为活性成分的鼠李糖（均聚多糖），鼠李糖或鼠李糖寡聚物。 鼠李糖通过从含有硫酸鼠李糖的藻类中分离出硫酸鼠李糖并且将硫酸鼠李糖硫酸盐脱硫来制备。 通过水解通过硫酸鼠李糖硫酸脱硫获得的鼠李糖或通过水解分离的双歧杆菌或多糖的微生物细胞来制备鼠李糖低聚物。

    Antibacterial agents and process for producing the same
    3.
    发明申请
    Antibacterial agents and process for producing the same 失效
    抗菌剂及其制造方法

    公开(公告)号：US20050130934A1

    公开(公告)日：2005-06-16

    申请号：US11049423

    申请日：2005-02-02

    申请人： Masato Nagaoka ,  Hideyuki Shibata ,  Itsuko Takagi ,  Shusuke Hashimoto

    发明人： Masato Nagaoka ,  Hideyuki Shibata ,  Itsuko Takagi ,  Shusuke Hashimoto

    IPC分类号： A61K31/731 ,  A61K31/737 ,  C08B37/00

    CPC分类号： A61K31/702 ,  A61K31/731 ,  A61K31/737

    摘要： An antibacterial agent showing a high affinity for Helicobactor pyroli and having an antibacterial effect specific to H. Pyroli. The agent has a chemical structure wherein an antibacterial substance is bonded to a sulfated polysaccharide or an oligosaccharide prepared by partial decomposition of the sulfated polysaccharide. Preferable embodiments are those having the chemical structure represented by Y—OCH(AH2NHR)n or Y—BH2NHR, wherein Y represents a sulfated polysaccharide or an oligosaccharide prepared by partial decomposition of the sulfated polysaccharide; A a carbon derived from aldehyde group occurring through the reduction of the reduced end sugar of Y and subsequent oxidation of the resulting product with an oxidant; B a carbon derived from the aldehyde group at the reduced end sugar of Y; R an antibacterial substance with a primary amino group or with an amino group introduced therein or represents an antibacterial substance derivative prepared by bonding an antibacterial substance through a spacer to the carbon A or the carbon B; and n=1 or 2.

    摘要翻译： 对Helicobactor pyroli具有高亲和力并具有对H. Pyroli特异性的抗菌作用的抗菌剂。 该药剂具有抗菌物质与通过硫酸化多糖的部分分解制备的硫酸化多糖或寡糖结合的化学结构。 优选的实施方案是具有由Y-OCH（AHN 2 NHR）n或Y-BH 2 NHR表示的化学结构的那些，其中Y表示 通过硫酸化多糖的部分分解制备的硫酸化多糖或寡糖; 衍生自醛基的碳通过还原末端糖的Y而发生，随后用氧化剂氧化所得产物; B是衍生自Y的还原末端糖的醛基的碳; R是具有伯氨基或在其中引入氨基的抗菌物质，或代表通过间隔剂将抗菌物质与碳A或碳B结合而制备的抗菌物质衍生物; n = 1或2。

    Breast cancer resistance protein (bcrp) inhibitor
    5.
    发明申请
    Breast cancer resistance protein (bcrp) inhibitor 失效
    乳腺癌抗性蛋白（bcrp）抑制剂

    公开(公告)号：US20060128636A1

    公开(公告)日：2006-06-15

    申请号：US10544064

    申请日：2004-02-03

    申请人： Ryuta Yamazaki ,  Yukiko Nishiyama ,  Tomio Furuta ,  Takeshi Matsuzaki ,  Hiroshi Hatano ,  Oh Yoshida ,  Masato Nagaoka ,  Ritsuo Aiyama ,  Shusuke Hashimoto ,  Yoshikazu Sugimoto

    发明人： Ryuta Yamazaki ,  Yukiko Nishiyama ,  Tomio Furuta ,  Takeshi Matsuzaki ,  Hiroshi Hatano ,  Oh Yoshida ,  Masato Nagaoka ,  Ritsuo Aiyama ,  Shusuke Hashimoto ,  Yoshikazu Sugimoto

    IPC分类号： A61K31/7034 ,  A61K31/277 ,  A61K31/66

    CPC分类号： C07D211/58 ,  A61K31/277 ,  A61K31/7034 ,  C07C255/37 ,  C07D317/60

    摘要： The invention provides a drug which inhibits BCRP. A breast cancer resistance protein inhibitor containing, as an active ingredient, a diphenylacrylonitrile derivative represented by the following formula (1): [wherein, each of 8 R's, which are the same or different from one another, represents a hydrogen atom, a hydroxyl group, a nitro group, an amino group, an acetylamino group (—NHCOCH3 group); a cyano group (—CN group); a formyl group (—CHO group), —COOR1 (R1 is hydrogen or C1-C4 alkyl), —O(CH2)nCOOR2 (n=1−7: R2 is hydrogen or C1-C4 alkyl), —OOCCH2CH2COOR3 (R3 is hydrogen, C1-C4 alkyl, (Z)-2-(3,4-dimethoxy-phenyl)-3-(4-hydroxy-phenyl)-acrylonitrile, or glycopyranosyl), a C1-C8 alkoxy group, a C1-C4 alkyl group, a halogen atom, a C1-C4 alkoxy C1-C4 alkoxy C1-C4 alkoxy group, a C2-C8 acyloxy group, a C2-C8 halogenoacyloxy group, a methylenedioxy group, a trifluoromethyl group, a phosphate group (i.e., —OP(O) (OH)2) or a salt thereof, a sulfate group (i.e., —OSO3H) or a salt thereof, a glycopyranosyl group or a salt thereof, a phosphate ester of a glycopyranosyl group or a salt of the ester, a sulfate ester of a glycopyranosyl group or a salt of the ester, or a piperidinopiperidinocarbonyloxy group], an ester thereof, or a salt thereof.

    摘要翻译： 本发明提供抑制BCRP的药物。 作为活性成分，含有下述式（1）表示的二苯基丙烯腈衍生物的乳
    球癌抗性蛋白质抑制剂：[其中，8个相同或不同的8个R代表氢原子，羟基 基团，硝基，氨基，乙酰氨基（-NHCOCH 3 SO 3）; 氰基（-CN基）; 甲酰基（-CHO基），-COOR 1（R 1是氢或C 1 -C 4烷基），-O（CH 2） ）nOR 2（n = 1-7：R 2是氢或C 1 -C 4烷基），-OOCCH 2 （R 3）是氢，C 1 -C 4烷基，（Z）-2-（3,4-二氯苯基） 二甲氧基 - 苯基）-3-（4-羟基 - 苯基） - 丙烯腈或糖吡喃糖基），C1-C8烷氧基，C1-C4烷基，卤素原子，C1-C4烷氧基C1-C4烷氧基C1- C4烷氧基，C2-C8酰氧基，C2-C8卤代酰氧基，亚甲二氧基，三氟甲基，磷酸基（即-OP（O）（OH）2））或 其盐，硫酸基（即-OSO 3 H）或其盐，糖吡喃糖基或其盐，糖吡喃糖基的磷酸酯或酯的盐， 糖吡喃糖基的硫酸酯或酯的盐或哌啶子基哌啶羰基氧基]，其酯或其盐。

    Antibacterial agents and process for producing the same
    8.
    发明授权
    Antibacterial agents and process for producing the same 失效
    抗菌剂及其制造方法

    公开(公告)号：US07498317B2

    公开(公告)日：2009-03-03

    申请号：US11049423

    申请日：2005-02-02

    申请人： Masato Nagaoka ,  Hideyuki Shibata ,  Itsuko Takagi ,  Shusuke Hashimoto

    发明人： Masato Nagaoka ,  Hideyuki Shibata ,  Itsuko Takagi ,  Shusuke Hashimoto

    IPC分类号： A61K31/731 ,  A61K31/737

    CPC分类号： A61K31/702 ,  A61K31/731 ,  A61K31/737

    摘要： An antibacterial agent showing a high affinity for Helicobactor pyroli and having an antibacterial effect specific to H. Pyroli. The agent has a chemical structure wherein an antibacterial substance is bonded to a sulfated polysaccharide or an oligosaccharide prepared by partial decomposition of the sulfated polysaccharide. Preferable embodiments are those having the chemical structure represented by Y—OCH(AH2NHR)n or Y—BH2NHR, wherein Y represents a sulfated polysaccharide or an oligosaccharide prepared by partial decomposition of the sulfated polysaccharide; A a carbon derived from aldehyde group occurring through the reduction of the reduced end sugar of Y and subsequent oxidation of the resulting product with an oxidant; B a carbon derived from the aldehyde group at the reduced end sugar of Y; R an antibacterial substance with a primary amino group or with an amino group introduced therein or represents an antibacterial substance derivative prepared by bonding an antibacterial substance through a spacer to the carbon A or the carbon B; and n=1 or 2.

    摘要翻译： 对Helicobactor pyroli具有高亲和力并具有对H. Pyroli特异性的抗菌作用的抗菌剂。 该药剂具有抗菌物质与通过硫酸化多糖的部分分解制备的硫酸化多糖或寡糖结合的化学结构。 优选的实施方案是具有由Y-OCH（AH2NHR）n或Y-BH2NHR表示的化学结构的那些，其中Y表示硫酸化多糖或通过硫酸化多糖的部分分解制备的寡糖; 衍生自醛基的碳通过还原末端糖的Y而发生，随后用氧化剂氧化所得产物; B是衍生自Y的还原末端糖的醛基的碳; R是具有伯氨基或在其中引入氨基的抗菌物质，或代表通过间隔剂将抗菌物质与碳A或碳B结合而制备的抗菌物质衍生物; n = 1或2。

    Breast cancer resistance protein (BCRP) inhibitor
    10.
    发明授权
    Breast cancer resistance protein (BCRP) inhibitor 失效
    乳腺癌抗性蛋白（BCRP）抑制剂

    公开(公告)号：US07371773B2

    公开(公告)日：2008-05-13

    申请号：US10544064

    申请日：2004-02-03

    申请人： Ryuta Yamazaki ,  Yukiko Nishiyama ,  Tomio Furuta ,  Takeshi Matsuzaki ,  Hiroshi Hatano ,  Oh Yoshida ,  Masato Nagaoka ,  Ritsuo Aiyama ,  Shusuke Hashimoto ,  Yoshikazu Sugimoto

    发明人： Ryuta Yamazaki ,  Yukiko Nishiyama ,  Tomio Furuta ,  Takeshi Matsuzaki ,  Hiroshi Hatano ,  Oh Yoshida ,  Masato Nagaoka ,  Ritsuo Aiyama ,  Shusuke Hashimoto ,  Yoshikazu Sugimoto

    IPC分类号： A61K31/415

    CPC分类号： C07D211/58 ,  A61K31/277 ,  A61K31/7034 ,  C07C255/37 ,  C07D317/60

    摘要： The invention provides a drug which inhibits BCRP.A breast cancer resistance protein inhibitor containing, as an active ingredient, a diphenylacrylonitrile derivative represented by the following formula (1): [wherein, each of 8 R's, which are the same or different from one another, represents a hydrogen atom, a hydroxyl group, a nitro group, an amino group, an acetylamino group (—NHCOCH3 group); a cyano group (—CN group); a formyl group (—CHO group), —COOR1 (R1 is hydrogen or C1-C4 alkyl), —O(CH2)nCOOR2 (n=1−7: R2 is hydrogen or C1-C4 alkyl), —OOCCH2CH2COOR3 (R3 is hydrogen, C1-C4 alkyl, (Z)-2-(3,4-dimethoxy-phenyl)-3-(4-hydroxy-phenyl)-acrylonitrile, or glycopyranosyl), a C1-C8 alkoxy group, a C1-C4 alkyl group, a halogen atom, a C1-C4 alkoxy C1-C4 alkoxy C1-C4 alkoxy group, a C2-C8 acyloxy group, a C2-C8 halogenoacyloxy group, a methylenedioxy group, a trifluoromethyl group, a phosphate group (i.e., —OP(O) (OH)2) or a salt thereof, a sulfate group (i.e., —OSO3H) or a salt thereof, a glycopyranosyl group or a salt thereof, a phosphate ester of a glycopyranosyl group or a salt of the ester, a sulfate ester of a glycopyranosyl group or a salt of the ester, or a piperidinopiperidinocarbonyloxy group], an ester thereof, or a salt thereof.

    摘要翻译： 本发明提供抑制BCRP的药物。 作为活性成分，含有下述式（1）表示的二苯基丙烯腈衍生物的乳
    球癌抗性蛋白质抑制剂：[其中，8个相同或不同的8个R代表氢原子，羟基 基团，硝基，氨基，乙酰氨基（-NHCOCH 3 SO 3）; 氰基（-CN基）; 甲酰基（-CHO基），-COOR 1（R 1是氢或C 1 -C 4烷基），-O（CH 2） ）nOR 2（n = 1-7：R 2是氢或C 1 -C 4烷基），-OOCCH 2 （R 3）是氢，C 1 -C 4烷基，（Z）-2-（3,4-二氯苯基） 二甲氧基 - 苯基）-3-（4-羟基 - 苯基） - 丙烯腈或糖吡喃糖基），C1-C8烷氧基，C1-C4烷基，卤素原子，C1-C4烷氧基C1-C4烷氧基C1- C4烷氧基，C2-C8酰氧基，C2-C8卤代酰氧基，亚甲二氧基，三氟甲基，磷酸基（即-OP（O）（OH）2））或 其盐，硫酸基（即-OSO 3 H）或其盐，糖吡喃糖基或其盐，糖吡喃糖基的磷酸酯或酯的盐， 糖吡喃糖基的硫酸酯或酯的盐或哌啶子基哌啶羰基氧基]，其酯或其盐。